Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Oros, Kathleen K ^a   Leblanc, Guy ^a   Arcand, Suzanna L ^b   Shen, Zhen ^b   Perret, Chantal ^c   Mes Masson, Anne Marie ^c,d   Foulkes, William D ^a,b   Ghadirian, Parviz ^c   Provencher, Diane ^c,d   Tonin, Patricia N ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANADA; COMPUTER PROGRAM; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; FOUNDER EFFECT; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC RECOMBINATION; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; OVARY CANCER;

ADULT; AGED; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; FOUNDER EFFECT; FRANCE; GENE FREQUENCY; GENES, BRCA2; HAPLOTYPES; HETEROZYGOTE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; QUEBEC; SEQUENCE DELETION;

EID: 33646736132     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-23     Document Type: Article

References (24)

1. Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA: Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 1998, 63:1341-1351.
2. Claus EB, Schildkraut JM, Thompson WD, Risch NJ: The genetic attributable risk of breast and ovarian cancer. Cancer 1996, 77:2318-2324.
3. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994, 343:692-695.
4. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, et al.: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998, 62:676-689.
5. Hopper JL, Southey MC, Dite GS, Jolley DJ, Giles GG, McCredie MR, Easton DF, Venter DJ: Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 1999, 8:741-747.
6. Chappuis PO, Hamel N, Paradis AJ, Deschenes J, Robidoux A, Potvin C, Cantin J, Tonin P, Ghadirian P, Foulkes WD: Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. Clin Genet 2001, 59:418-423.
7. Tonin PM, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D: Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history. Clin Genet 1999, 55:318-324.
8. Tonin PN, Perret C, Lambert JA, Paradis AJ, Kantemiroff T, Benoit MH, Martin G, Foulkes WD, Ghadirian P: Founder BRCA1 and BRCA2 mutations in early-onset French Canadian breast cancer cases unselected for family history. Int J Cancer 2001, 95:189-193.
9. Manning AP, Abelovich D, Ghadirian P, Lambert JA, Frappier D, Provencher D, Robidoux A, Peretz T, Narod SA, Mes-Masson AM, et al.: Haplotype analysis of BRCA2 8765deIAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered 2001, 52:116-120.
10. Oros KK, Ghadirian P, Greenwood CM, Perret C, Shen Z, Paredes Y, Arcand SL, Mes-Masson AM, Narod SA, Foulkes WD, et al.: Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations. Int J Cancer 2004, 112:411.
11. Couch FJ, Rommens JM, Neuhausen SL, Belanger C, Dumont M, Abel K, Bell R, Berry S, Bogden R, Cannon-Albright L, et al.: Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics 1996, 36:86-99.
12. Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, et al.: Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 1998, 62:1381-1388.
13. Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
14. Stephens M, Donnelly P: A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003, 73:1162-1169.
15. UCSC Genome Browser> [http://genome.ucsc.edu/]
16. Ellegren H: The human Momo Sapiens genome Browser gateway: The UCSC Genome Bioinfomatics. Nat Rev Genet 2004, 5:435-445.
17. The Breast Cancer Information Core (BIC): An Open Access on-Line Data Base Breast Cancer Mutation [http://research.nhgri.nih.gov/bic/]
18. Couch FJ, Weber BL: Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum Mutat 1996, 8:8-18.
19. Thompson D, Easton D: Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001, 68:410-419.
20. Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics 1998. 1998 [http://www.cancer.ca/ccs/internet/ standard/0.3182.3172_14279_langld-en.00.html]. Toronto, Canada
21. Levine DA, Argenta PA, Yee CJ, Marshall DS, Olvera N, Bogomolniy F, Rahaman JA, Robson ME, Offit K, Barakat RR, et al.: Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations. J Clin Oncol 2003, 21:4222-4227.
22. Johannsson O, Ostermeyer EA, Hakansson S, Friedman LS, Johansson U, Sellberg G, Brondum-Nielsen K, Sele V, Olsson H, King MC, et al.: Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. J Hum Genet 1996, 58:441-450.
23. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, et al.: Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 1996, 13:120-122.
24. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D: The human genome browser at UCSC. Genome Res 2005, 6:996-1006.